ADMA Biologics Inc - Common Stock — 四半期キャッシュフロー (NASDAQ:ADMA) | MetaTrader

チャート全体を表示 Full chart

Financials

概要明細書統計

総資産 488.68 M510.57 M558.38 M568.69 M624.24 M665.18 M 負債合計 139.66 M137.15 M160.06 M137.5 M146.92 M274.86 M 純資産合計 349.02 M373.42 M398.32 M431.19 M477.32 M390.32 M 負債および純資産合計 488.68 M510.57 M558.38 M568.69 M624.24 M665.18 M 有利子負債合計 72.34 M72.53 M73.4 M72.43 M72.14 M196.87 M 純負債 -30.81 M902 K-16.89 M8.7 M-18.3 M58.71 M

ニュース

ADMA vs Intellia Therapeutics: Which Biotech Stock Is a Better Pick Now?

Can Asceniv Help ADMA Navigate the Current IG Market Challenges?

New Strong Sell Stocks for May 26th

Will the IG Market Challenges Affect ADMA Biologics Prospects in 2026?

Is it Time to Exit ADMA Biologics Stock After a 22% Monthly Plunge?

スタンレー・ドラッケンミラーがアマゾンとアルファベットを売却し、一方でコモディティ、アルゼンチン、バイオテックに積極投資

Is Adma Biologics (ADMA) a Buy as Wall Street Analysts Look Optimistic?

New Strong Sell Stocks for May 14th

New Strong Sell Stocks for May 11th

ADMA Q1 EPS Jumps 73% Y/Y, Revenues Slip, 2026 View Down

Will the Label Expansion of Asceniv Boost ADMA's Top-Line Growth?

Adma Biologics (ADMA) Dips More Than Broader Market: What You Should Know